The undisputed power of artificial intelligence (AI) has disrupted countless industries in recent years, and biotech/pharma is no exception. Leveraging the power of sophisticated Large Language Models (LLM), Natural Language Processing (NLP) and Machine Learning (ML) algorithms is critical to offering cutting-edge services and solutions that give our clients the competitive edge and first mover advantage, regardless of your desired target platform.
That’s why we’ve launched EMH AI, a dedicated suite of proprietary AI-based services and solutions to ensure that our clients stay ahead of the game. We offer full lifecycle support, from back-end server setup and local model training through to deployment and front-end UX experience, with all the maintenance and support provided in-house.
We have integrated a number of AI technologies into recent projects, including ML-based computer vision algorithms used to detect changes in patient faces for a recent mobile app we developed.
To see more examples, check out our showcase project page. But for now we want to focus on next-gen applications of these technologies, in which we forsee AI playing a transformative role in the way companies run, deploy and manage their services.
Virtual Medical Science Liaisons (VMSL) and Virtual Key Account Managers (VKAM)
In the fast-paced world of biotechnology and pharmaceuticals, accurate, timely, and reliable communication is paramount. VMSLs and VKAMs are quickly becoming game-changers for biopharma
companies seeking to enhance their interactions with healthcare professionals. Powered by AI, these virtual roles are transforming how medical and scientific information is delivered, offering both convenience and cost-saving benefits, including 24/7 platform-agnostic access to 100% medically accurate Information; tailor-made responses to specific questions; cost efficiency; and improved business strategy. Furthermore, because the virtual assistant can tailor its responses to the needs of the user, the
experience is both flexible and personalized. Whether brief or extended, the information provided in the conversation is always relevant and fully accurate.
Interested in seeing an interactive demo of our VMSL or other EMH AI services for yourself? Contact mark [at] empatheticmedia [dot] com to arrange a virtual meeting when we can show you this cutting-edge tech first-hand.
The Future of Pharma Communication
As AI continues to evolve, the role of virtual medical and scientific liaisons will only grow. The combination of constant availability, cost savings, and reliable, unbiased information makes VMSLs and VKAMs an attractive solution for biotechnology and pharmaceutical companies looking to improve their communication with healthcare professionals.